Grouping heart failure patients by clinical data and exercise test responses
Reviews past records of adults with heart failure to find patient subgroups.
Key facts
- Who runs it
- Instituto Politécnico de Leiria
- Where
- Leiria, PortugalSee the 2 sites
- Trial code
- Registry title
- Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction
- Status
- Not yet recruiting
- People taking part
- 200 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 31 May 2028
- Type of study
- Observational
- Record updated
- 24 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with heart failure with preserved ejection fraction (HFpEF). First, past records are reviewed; a smaller group then does one exercise test visit.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Established diagnosis of heart failure with preserved ejection fraction (LVEF ≥50%).
Main reasons for not taking part
- Incomplete or inadequate medical records (records review phase)
- Medical reason or physical inability that prevents the exercise test (CPET)
- Cannot give informed consent (exercise test phase)
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Retropective observational phase (Phase I):; Age ≥18 years; Established diagnosis of heart failure with preserved ejection fraction (LVEF ≥50%); Patients receiving care (outpatient or inpatient) at the Local Health Unit of the Leiria Region (ULS RL) since September 2018
- Cross-sectional observational phase (Phase II - CPET):; Age ≥18 years; Established diagnosis of HFpEF; Selection as a volunteer representative of phenotypes identified in the retrospective clustering analysis; Provision of written informed consent prior to any study-specific procedures
Who cannot take part
- Retropective observational phase (Phase I):; Incomplete or inadequate medical records preventing full data extraction
- Cross-sectional observational phase (Phase II - CPET):; Medical contraindication or physical inability to perform cardiopulmonary exercise testing (CPET); Inability to provide informed consent
Where in Portugal
- ciTechCare - Center for Innovative Care and Health TechnologyLeiria, PortugalContact: Maria P S Guarino, PhDNo longer taking part
- Local Health Unit of the Leiria RegionLeiria, PortugalContact: Cristiana FernandesNo longer taking part
About the trial
What the trial wants to find out
The goal of this observational study is to learn how people with Heart Failure with Preserved Ejection Fraction (HFpEF) can be grouped into different "phenotypes" based on their clinical information. The researchers want to understand whether these groups have different health profiles and different responses during a cardiopulmonary exercise test (CPET).
Read full original descriptionShow less
The main questions this study aims to answer are:
* Can clinical data be used to identify meaningful HFpEF phenotypes? * Do these phenotypes match well-known HFpEF scores, such as the H2FPEF and Heart Failure Association Pre-test Assessment, Echocardiography and Natriuretic Peptide (HFA-PEFF) scores? * Do people in different phenotypes show different results on a CPET?
Participants will:
* Have their past clinical records reviewed if they were diagnosed with HFpEF at the Local Health Unit of the Leiria Region (ULS RL); * A smaller group will attend one visit to complete a CPET, which measures how the heart, lungs and muscles respond during exercise.
This study includes adults aged 18 years or older who have HFpEF. The study does not involve any new treatments or experimental drugs.
The group in the trial
- Observational HFpEF Cohort
Single observational cohort including all adults with an established diagnosis of heart failure with preserved ejection fraction (LVEF ≥50%) who received care at the Local Health Unit of the Leiria Region (ULS RL) since September 2018. Clinical, biochemical, imaging, functional, and therapeutic information recorded during previous hospitalizations will be extracted for retrospective analysis. A subset of participants will later be invited to complete a single cardiopulmonary exercise test (CPET) according to the study protocol. Phenotypes (clusters) will be identified post-hoc using unsupervised machine-learning methods and are not predefined at the time of enrollment.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction
- Plain-language title
- Grouping heart failure patients by clinical data and exercise test responsesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 24 February 2026